The DOI matches its Crossref record; 198 of the 199 references it cites were found in a registry or an index.
The P2X7 Receptor in Infection and Inflammation
Open accessAbstract
Adenosine triphosphate (ATP) accumulates at sites of tissue injury and inflammation. Effects of extracellular ATP are mediated by plasma membrane receptors named P2 receptors (P2Rs). The P2R most involved in inflammation and immunity is the P2X7 receptor (P2X7R), expressed by virtually all cells of innate and adaptive immunity. P2X7R mediates NLRP3 inflammasome activation, cytokine and chemokine release, T lymphocyte survival and differentiation, transcription factor activation, and cell death. Ten human P2RX7 gene splice variants and several SNPs that produce complex haplotypes are known. The P2X7R is a potent stimulant of inflammation and immunity and a promoter of cancer cell growth. This makes P2X7R an appealing target for anti-inflammatory and anti-cancer therapy. However, an in-depth knowledge of its structure and of the associated signal transduction mechanisms is needed for an effective therapeutic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“P2X7, which is widely expressed by immune cells, is the most studied purinergic receptors involved in neurodegeneration.374,375”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [374]
Experimental — accuracy not yet measuredIn the citing paper
“Hyperactivation of P2X7 receptors is closely related to inflammatory processes since they are stimulated by ATP released from distressed cells and induce inflammasome activation [16–18].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“In these circumstances, ATP may act as DAMP, which activates the nuclear transcription factor NF-κB resulting in expression upregulation of pro-IL-1β and pro-IL-18 and the NLRP3 protein [16, 71].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“Consequently, there is an activation of caspase-1 and maturation of IL-1β and IL-18, resulting in pro-inflammatory cytokine release [16, 20, 52, 71, 73].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“The P2X7 receptor is a major activator of the NLRP3 inflammasome in several cell types [16], including macrophages and microglial cells [72, 74–76].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“In fact, the role of P2X7 receptor as a modulator of inflammatory response is well-established [16, 70].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“The massive ATP release following lung mononuclear phagocytes invasion by SARS-CoV-2 can activate P2X7 receptors of antigen-presenting cells and macrophages, increasing cytokine, chemokine and ATP secretion [16].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
In the citing paper
“As discussed by Di Virgilio et al. [106], many processes associated with lung impairment, as seen in COVID-19 patients, are mediated by P2X7 receptors [16].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G. J., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,167
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
Coull, J. A. M., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M. W., & De Koninck, Y. (2005) · Nature · doi:10.1038/nature04223 · Cited by 1,965
Flagged first, then by citations
1 of the 199 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Gong, T., Liu, L., Jiang, W., & Zhou, R. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0215-7 · Cited by 1,672
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
Pyroptosis versus necroptosis: similarities, differences, and crosstalk
Frank, D., & Vince, J. E. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0212-6 · Cited by 1,062
Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential
Inoue, K., & Tsuda, M. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.2 · Cited by 908
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
Virgilio, F. D., Sarti, A. C., Falzoni, S., Marchi, E. D., & Adinolfi, E. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0037-0 · Cited by 748
Self-citationRole of pyroptosis in inflammation and cancer
Xiang, W. D., Xie, F., Zhou, X., Wu, Y., Yan, H., Liu, T., Huang, J. S., Wang, F., Zhou, F., & Zhang, L. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00905-x · Cited by 728
Mitochondria in health, disease, and aging
Harrington, J. S., Ryter, S. W., Plataki, M. E., Price, D. R., & Choi, A. M. K. (2023) · Physiological Reviews · doi:10.1152/physrev.00058.2021 · Cited by 641
Trebak, M., & Kinet, J.-P. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-018-0110-7 · Cited by 506
From purines to purinergic signalling: molecular functions and human diseases
Huang, Z., Xie, N., Illés, P., Virgilio, F. D., Ulrich, H., Semyanov, A. V., Verkhratsky, A., Sperlágh, B., Yu, S., Huang, C., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00553-z · Cited by 534
“Functional P2X7 receptor is a trimeric complex with a variable conformation switches between open (ATP-bound) and closed states, which is one of the most intensively studied purinergic receptors that shapes immune responses.(225,226) Mounting evidence suggests that P2X7 receptors control cytokine release and immune ce…”
BackgroundThe P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Savio, L. E. B., de Andrade Mello, P., da Silva, C. G., & Coutinho-Silva, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00052 · Cited by 437
Han, X., Sun, S., Sun, Y., Song, Q., Zhu, J., Song, N., Chen, M., Sun, T., Xia, M., Ding, J., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1596481 · Cited by 408
Targeting the NLRP3 Inflammasome in Severe COVID-19
Freeman, T. L., & Swartz, T. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01518 · Cited by 413
The gut–joint axis in rheumatoid arthritis
Zaiss, M. M., Wu, H.-J. J., Mauro, D., Schett, G. A., & Ciccia, F. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00585-3 · Cited by 412
The P2X7 receptor: A main player in inflammation
Adinolfi, E., Giuliani, A. L., De Marchi, E., Pegoraro, A., Orioli, E., & Di Virgilio, F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.021 · Cited by 385
Self-citationMitochondria-associated membranes (MAMs) and inflammation
Missiroli, S., Patergnani, S., Caroccia, N., Pedriali, G., Perrone, M., Previati, M., Wieckowski, M. R., & Giorgi, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0027-2 · Cited by 398
Immune regulation by microbiome metabolites
Kim, C. H. (2018) · Immunology · doi:10.1111/imm.12930 · Cited by 375
Purine Release, Metabolism, and Signaling in the Inflammatory Response
Linden, J. M., Koch‐Nolte, F., & Dahl, G. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052406 · Cited by 389
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Moesta, A. K., Li, X.-Y., & Smyth, M. J. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0376-4 · Cited by 332
New keys for old locks: carborane-containing drugs as platforms for mechanism-based therapies
Stockmann, P., Gozzi, M., Kuhnert, R., Sárosi, M. B., & Hey‐Hawkins, E. (2019) · Chemical Society Reviews · doi:10.1039/c9cs00197b · Cited by 317
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
Illés, P., Müller, C. E., Jacobson, K. A., Grütter, T., Nicke, A., Fountain, S. J., Kennedy, C., Schmalzing, G., Jarvis, M. F., Stojilković, S. S., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15299 · Cited by 327
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
Di Virgilio, F., Schmalzing, G., & Markwardt, F. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.01.005 · Cited by 279
Lüscher, B., Bütepage, M., Eckei, L., Krieg, S., Verheugd, P., & Shilton, B. H. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00122 · Cited by 264
The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells
da Silva, H. B., Beura, L. K., Wang, H., Hanse, E. A., Gore, R., Scott, M. C., Walsh, D., Block, K. E., Fonseca, R., Yan, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0282-0 · Cited by 259
Regulation of phospholipid distribution in the lipid bilayer by flippases and scramblases
Sakuragi, T., & Nagata, S. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00604-z · Cited by 278
Extracellular ATP: A Feasible Target for Cancer Therapy
Vultaggio-Poma, V., Sarti, A. C., & Virgilio, F. D. (2020) · Cells · doi:10.3390/cells9112496 · Cited by 259
“Over the years, a role for eATP has been identified in several, different physiological and pathological conditions such as [12]: glial-neuron interaction [13], sensory transmission [14], hormone secretion [15], disorders of central nervous system [16], cardiovascular diseases [17], infection [18], inflammation [19] a…”
BackgroundSelf-citationBurnstock, G., & Knight, G. E. (2018) · Purinergic Signalling · doi:10.1007/s11302-017-9593-0 · Cited by 248
P2X7 receptor and the NLRP3 inflammasome: Partners in crime
Pelegrín, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114385 · Cited by 253
Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS
Illés, P., Rubini, P., Ulrich, H., Zhao, Y., & Tang, Y. (2020) · Cells · doi:10.3390/cells9051108 · Cited by 249
Purinergic signaling, DAMPs, and inflammation
Virgilio, F. D., Sarti, A. C., & Coutinho‐Silva, R. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00053.2020 · Cited by 237
“In the IME and TME, ATP release and degradation (and therefore adenosine generation) are closely correlated; thus the final effect is often a result of the stimulation of both P2Rs and P1Rs, as it is clearly shown in the case of polymorphonuclear leukocyte chemotaxis, which is dependent on both P2Y2R and A3R stimulati…”
BackgroundSelf-citationMartínez-García, J. J., Martínez-Banaclocha, H., Angosto-Bazarra, D., de Torre-Minguela, C., Baroja-Mazo, A., Alarcón-Vila, C., Martínez-Alarcón, L., Amores-Iniesta, J., Martín-Sánchez, F., Ercole, G. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10626-x · Cited by 233
P2X7 Interactions and Signaling – Making Head or Tail of It
Kopp, R., Krautloher, A., Ramírez-Fernández, A., & Nicke, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00183 · Cited by 217
Extracellular nucleotides and nucleosides as signalling molecules
Giuliani, A. L., Sarti, A. C., & Virgilio, F. D. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.11.006 · Cited by 230
Self-citationRe-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody
Kaczmarek-Hájek, K., Zhang, J., Kopp, R., Grosche, A., Rissiek, B., Saul, A., Bruzzone, S., Engel, T., Jooss, T., Durner, A., et al. (2018) · eLife · doi:10.7554/elife.36217 · Cited by 218
Vujkovic, M., Ramdas, S., Lorenz, K. M., Guo, X., Darlay, R., Cordell, H. J., He, J., Gindin, Y., Chung, C., Myers, R. P., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01078-z · Cited by 205
The Concise Guide to PHARMACOLOGY 2023/24: Ion channels
Alexander, S. P. H., Mathie, A. A., Peters, J. A., Veale, E. L., Striessnig, J., Kelly, E., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16178 · Cited by 204
Self-citationGilbert, S. M., Oliphant, C. J., Hassan, S., Peille, A., Bronsert, P., Falzoni, S., Virgilio, F. D., McNulty, S., & Lara, R. (2018) · Oncogene · doi:10.1038/s41388-018-0426-6 · Cited by 205
Self-citationMarchi, E. D., Orioli, E., Pegoraro, A., Sangaletti, S., Portararo, P., Curti, A., Colombo, M. P., Virgilio, F. D., & Adinolfi, E. (2019) · Oncogene · doi:10.1038/s41388-019-0684-y · Cited by 205
CD39 Regulation and Functions in T Cells
Timperi, E., & Barnaba, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158068 · Cited by 191
Wei, Q., Zhu, R., Zhu, J., Zhao, R., & Li, M. (2019) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15462920753012 · Cited by 185
Kong, H., Zhao, H., Chen, T., Song, Y., & Cui, Y. T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04786-w · Cited by 189
“Dysregulation of the overactive P2X7 calcium signal dysregulation is critical for the death of neurons and microvascular cells [55].”
Amores, J., Barberà-Cremades, M., Martínez, C. M., Pons, J. A., Revilla‐Nuin, B., Martínez-Alarcón, L., Virgilio, F. D., Parrilla, P., Baroja‐Mazo, A., & Pelegrín, P. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.079 · Cited by 187
Hepatic macrophages: Key players in the development and progression of liver fibrosis
Cheng, D., Chai, J., Wang, H., Fu, L., Peng, S., & Ni, X. (2021) · Liver International · doi:10.1111/liv.14940 · Cited by 188
Quan, J., Huang, R., Wang, Z., Huang, S., Choi, I.-W., Zhou, Y. J., Lee, Y., & Chu, J. (2018) · Parasites & Vectors · doi:10.1186/s13071-017-2573-y · Cited by 170
Chronic pain and neuroinflammation
Vergne‐Salle, P., & Bertin, P. (2021) · Joint Bone Spine · doi:10.1016/j.jbspin.2021.105222 · Cited by 189
Macrophage Recognition of Crystals and Nanoparticles
NAKAYAMA, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00103 · Cited by 173
P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Lara, R., Adinolfi, E., Harwood, C. A., Philpott, M. P., Barden, J. A., Virgilio, F. D., & McNulty, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00793 · Cited by 174
Radiation-Induced Salivary Gland Dysfunction: Mechanisms, Therapeutics and Future Directions
Jasmer, K. J., Gilman, K. E., Forti, K. M., Weisman, G. A., & Limesand, K. H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124095 · Cited by 173
Targeting CD73 to augment cancer immunotherapy
Roh, M., Wainwright, D. A., Wu, J. D., Wan, Y., & Zhang, B. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.07.001 · Cited by 165
Innate immune activation in neurodegenerative diseases
Castro‐Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 176
P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice
Ruan, Z., Delpech, J.-C., Venkatesan Kalavai, S., Van Enoo, A. A., Hu, J., Ikezu, S., & Ikezu, T. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00396-2 · Cited by 150
“Activation of P2RX7 has been shown to trigger Na/Ca influx, plasma membrane depolarization, secretion of EVs, chemotaxis and activation of inflammasomes [9].”
BackgroundNová, Z., Škovierová, H., & Čalkovská, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040831 · Cited by 168
Human Microglia Show Unique Transcriptional Changes in Alzheimer's Disease
Prater, K. E., Green, K. J., Mamde, S., Sun, W., Cochoit, A., Smith, C. L., Chiou, K. L., Heath, L., Rose, S. E., Wiley, J., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00424-y · Cited by 164
PET Imaging of Neuroinflammation in Alzheimer’s Disease
Zhou, R., Ji, B., Kong, Y., Qin, L., Ren, W., Guan, Y., & Ni, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.739130 · Cited by 157
Calcium signalling and related ion channels in neutrophil recruitment and function
Immler, R., Simon, S. I., & Sperandio, M. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12964 · Cited by 158
Jaeschke, H., Adelusi, O. B., Akakpo, J. Y., Nguyen, N. T., Sánchez-Guerrero, G., Umbaugh, D. S., Ding, W., & Ramachandran, A. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.023 · Cited by 155
T RM maintenance is regulated by tissue damage via P2RX7
Stark, R., Wesselink, T. H., Behr, F. M., Kragten, N. A. M., Arens, R., Koch-Nolte, F., van Gisbergen, K. P. J. M., & van Lier, R. A. W. (2018) · Science Immunology · doi:10.1126/sciimmunol.aau1022 · Cited by 141
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
Nizami, S., Hall‐Roberts, H., Warrier, S., Cowley, S. A., & Di Daniel, E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14618 · Cited by 147
Karasawa, A., Michalski, K., Mikhelzon, P., & Kawate, T. (2017) · eLife · doi:10.7554/elife.31186 · Cited by 127
Stress induced microglial activation contributes to depression
Li, B., Yang, W., Ge, T., Wang, Y., & Cui, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106145 · Cited by 151
Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target
You, R., He, X., Zeng, Z., Zhan, Y., Xiao, Y., & Xiao, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841732 · Cited by 150
Control of adaptive immunity by pattern recognition receptors
Carroll, S. L., Pasare, C., & Barton, G. M. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.014 · Cited by 155
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease
Dwyer, K. M., Kishore, B. K., & Robson, S. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0304-7 · Cited by 148
Microglial phenotypes in the human epileptic temporal lobe
Morin‐Brureau, M., Milior, G., Royer, J., Chali, F., Duigou, C. L., Savary, E., Blugeon, C., Jourdren, L., Akbar, D., Dupont, S., et al. (2018) · Brain · doi:10.1093/brain/awy276 · Cited by 150
P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Illés, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175996 · Cited by 145
Macrophage as a Peripheral Pain Regulator
Domoto, R., Sekiguchi, F., Tsubota, M., & Kawabata, A. (2021) · Cells · doi:10.3390/cells10081881 · Cited by 137
“Activation of P2X7 receptors in macrophages induces IL-1β release via activation of Nod-like receptor protein (NLRP) 3 inflammasome [80,81], which might lead to pyroptosis [81,82].”
BackgroundOkada, T., Suzuki, H., Travis, Z. D., & Zhang, J. H. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528143301 · Cited by 141
“ATP binds to P2X7 receptor (P2X7R) located on cell surface of neurons and glial cells, and leads to activation of the downstream signaling NLRP3 inflammasome and MAPKs followed by production of proinflammatory substances resulting in BBB injury [288-295].”
BackgroundOn the mechanism of anti-CD39 immune checkpoint therapy
Allard, D., Allard, B., & Stagg, J. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000186 · Cited by 136
“13 For instance, localized activation of P2X4 promotes Ca 2+ influx in T cells and selective activation of mitochondria at the immune synapse.”
Ion channelopathies of the immune system
Vaeth, M., & Feske, S. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.021 · Cited by 132
Current understanding of meningeal and cerebral vascular function underlying migraine headache
Levy, D., Labastida‐Ramírez, A., & MaassenVanDenBrink, A. (2018) · Cephalalgia · doi:10.1177/0333102418771350 · Cited by 130
Li, Z., Huang, Z., Zhang, H., Lu, J., Tian, Y., Wei, Y., Yang, Y., & Bai, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8868361 · Cited by 131
“Overall, P2X7 regulates a series of signaling pathways involved in inflammation, including ion flow, protease activation, membrane response, and secretion [10].”
BackgroundThe NLRP3 inflammasome renders cell death pro-inflammatory
Gaidt, M. M., & Hornung, V. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.11.013 · Cited by 124
da Silva, H. B., Peng, C., Wang, H., Wanhainen, K. M., Ma, C., Lopez, S., Khoruts, A., Zhang, N., & Jameson, S. C. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.010 · Cited by 135
The Antisocial Network: Cross Talk Between Cell Death Programs in Host Defense
Snyder, A. G., & Oberst, A. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-112019-072301 · Cited by 129
“The P2X7 receptor in infection and inflammation.”
BackgroundJaeschke, H., & Ramachandran, A. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111240 · Cited by 130
Zhao, X., Wang, J., Deng, Y., Liao, L., Zhou, M., Peng, C. Y., & Li, Y. (2021) · Phytotherapy Research · doi:10.1002/ptr.7104 · Cited by 128
Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation
Xu, Z., Chen, Z.-M., Wu, X., Zhang, L., Cao, Y., & Zhou, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609441 · Cited by 127
Yu, L., Hong, W., Lu, S., Li, Y., Guan, Y., Weng, X., & Feng, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.780496 · Cited by 126
Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS–cGAMP–STING Pathway
Ritchie, C., Carozza, J. A., & Li, L. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-040320-101629 · Cited by 123
Xu, Q., Zhao, B., Ye, Y., Li, Y., Zhang, Y., Xiong, X., & Gu, L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02137-8 · Cited by 119
“crease in ATP concentration activates P2X7R, leading to intracellular K efflux that activates the NLRP3 inflammasome [88].”
BackgroundLiang, H., Chen, A., Lai, X., Liu, J., Wu, J., Kang, Y., Wang, X., & Shao, L. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0274-0 · Cited by 118
Extracellular ATP: A powerful inflammatory mediator in the central nervous system
Virgilio, F. D., Vultaggio-Poma, V., Falzoni, S., & Giuliani, A. L. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109333 · Cited by 126
Self-citationAlugoju, P., Swamy, V., Anthikapalli, N. V. A., & Tencomnao, T. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2084600 · Cited by 123
Fumagalli, M., Lecca, D., Abbracchio, M. P., & Ceruti, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00941 · Cited by 125
Regulation of coenzyme A levels by degradation: the ‘Ins and Outs’
Naquet, P., Kerr, E. W., Vickers, S. D., & Leonardi, R. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101028 · Cited by 119
“These metabolites modulate purinergic signaling and are involved in multiple processes such as neurotransmission, bone mineralization, inflammation and platelet aggregation [183].”
BackgroundMarine Alkaloids with Anti-Inflammatory Activity: Current Knowledge and Future Perspectives
Souza, C. R. D. M., Bezerra, W. P., & de Souto, J. T. (2020) · Marine Drugs · doi:10.3390/md18030147 · Cited by 114
“P2X7 receptors are ATP receptors involved in the activation of inflammatory response mechanisms, such as the activation of NLRP3 inflammasomes, the synthesis of proinflammatory cytokines and chemokines, the activation of MAPK and phospholipase C, and the activation of transcription factors involved in the expression o…”
BackgroundNabekura, T., Riggan, L., Hildreth, A. D., O’Sullivan, T. E., & Shibuya, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.11.004 · Cited by 109
Piezo1 expression in neutrophils regulates shear-induced NETosis
Baratchi, S., Danish, H., Chheang, C., Zhou, Y., Huang, A., Lai, A., Khanmohammadi, M., Quinn, K. M., Khoshmanesh, K., & Peter, K. (2024) · Nature Communications · doi:10.1038/s41467-024-51211-1 · Cited by 110
Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
Shao, B., Cao, Q., & Chong, L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00320 · Cited by 103
Shokoples, B. G., Paradis, P., & Schiffrin, E. L. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315116 · Cited by 104
Veeresh, P., Kaur, H., Sarmah, D., Mounica, L., Verma, G., Kotian, V., Kesharwani, R., Kalia, K., Borah, A., Wang, X., et al. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14212 · Cited by 98
Quercetin Attenuates Atherosclerotic Inflammation by Inhibiting Galectin‐3‐NLRP3 Signaling Pathway
Li, H., Xiao, L., He, H., Zeng, H., Liu, J., Jiang, C., Mei, G., Yu, J., Chen, H., Yao, P., et al. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000746 · Cited by 100
Focusing on mitochondria in the brain: from biology to therapeutics
Song, N., Mei, S., Wang, X.-X., Hu, G., & Lu, M. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00409-w · Cited by 111
“Moreover, extra-cellular ATP even functions as a DAMP by binding to purinergic receptors (mainly P2X7R) expressed on myeloid cells to mediate inflammatory responses, especially inflammasome activation [170, 171].”
BackgroundCalzaferri, F., Ruiz‐Ruiz, C., de Diego, A. M. G., de Pascual, R., Méndez‐López, I., Cano‐Abad, M. F., Maneu, V., Ríos, C. D. L., Gandía, L., & de Diego, A. M. G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21710 · Cited by 101
“BBG has been utilized in both in vitro and in vivo experiments; however, this compound also targets P2X4, P2X5, rat P2Y1, and P2Y2 receptors, as well as voltage‐gated sodium channels.8,95,96 BBG was initially the main compound used for the proof‐ of‐concept of P2X7Rs role in NDDs, such as ALS and AD.97–99 Its permeabi…”
BackgroundInfluentialNeuroinflammation in Sepsis: Molecular Pathways of Microglia Activation
Moraes, C. A., Zaverucha-do-Valle, C., Fleurance, R., Sharshar, T., Bozza, F. A., & d’Avila, J. C. (2021) · Pharmaceuticals · doi:10.3390/ph14050416 · Cited by 105
Durán-Flores, D., & Heil, M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.010 · Cited by 94
Metadata
- Authors
- Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S.
- Affiliations
- University of Ferrara (IT)
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 47
- Issue
- 1
- Pages
- 15-31
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2737555531
- Cited by
- 1,267
- References
- 199
- Citations by year
- 2026: 167 · 2025: 138 · 2024: 164 · 2023: 155 · 2022: 160 · 2021: 161 · 2020: 132 · 2019: 102 · 2018: 78 · 2017: 9
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Unicam Scientific Publications (University of Camerino) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by)
- Funders
- Italian Association for Cancer Research (IG 13025, IG 18581)
- Telethon of Italy (GGP06070)
- ERA-NET Neuron Joint Transnational Project “Nanostroke,” the Ministry of Health of Italy (RF-2011-02348435)
- Italian Ministry of Education, University and Research (RBAP11FXBC_001)
- University of Ferrara
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- P2X7 receptor, extracellular ATP, purinergic receptors, NLRP3 inflammasome, inflammation, innate immunity, adaptive immunity, cytokine and chemokine secretion, single nucleotide polymorphisms, cancer, anti-inflammatory therapy, cancer therapy, signal transduction, receptor structure
- MeSH terms
- Animals, Cell Differentiation, Humans, Infections, Inflammation, Macrophages, T-Lymphocytes, Receptors, Purinergic P2X7, Inflammasomes, Purinergic P2X Receptor Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
